BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9438460)

  • 1. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management.
    Rader AE; Rose PG; Rodriguez M; Mansbacher S; Pitlik D; Abdul-Karim FW
    Acta Cytol; 1999; 43(3):357-62. PubMed ID: 10349362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
    Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
    J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Howell LP; Davis RL
    Diagn Cytopathol; 1996 Feb; 14(1):20-4. PubMed ID: 8834072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital.
    Carpenter AB; Davey DD
    Cancer; 1999 Jun; 87(3):105-12. PubMed ID: 10385440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions.
    Morrison C; Prokorym P; Piquero C; Wakely PE; Nuovo GJ
    Cancer; 2003 Apr; 99(2):75-82. PubMed ID: 12704686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescreening of atypical cervicovaginal smears using PAPNET.
    Lerma E; Colomo L; Carreras A; Esteva E; Quilez M; Prat J
    Cancer; 1998 Dec; 84(6):361-5. PubMed ID: 9915138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
    Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
    Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women.
    Keating JT; Wang HH
    Cancer; 2001 Apr; 93(2):100-5. PubMed ID: 11309774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliminating the diagnosis atypical squamous cells of undetermined significance: impact on the accuracy of the Papanicolaou test.
    Sodhani P; Gupta S; Singh V; Sehgal A; Mitra AB
    Acta Cytol; 2004; 48(6):783-7. PubMed ID: 15581162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance.
    Ryan MR; Stastny JF; Remmers R; Pedigo MA; Cahill LA; Frable WJ
    Am J Clin Pathol; 1996 Jun; 105(6):711-8. PubMed ID: 8659445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality metrics in cervical cytopathology: A single institutional study.
    Senthil Kumar D; Ravikumar G
    Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASCUS on cervical cytologic smears. Clinical significance.
    Yang M; Zachariah S
    J Reprod Med; 1997 Jun; 42(6):329-31. PubMed ID: 9219118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualifiers of atypical squamous cells of undetermined significance help in patient management.
    Collins LC; Wang HH; Abu-Jawdeh GM
    Mod Pathol; 1996 Jun; 9(6):677-81. PubMed ID: 8782207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
    van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
    Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ASCUS findings in Papanicolaou smears. A retrospective study.
    Iavazzo C; Boutas I; Grigoriadis C; Vrachnis N; Salakos N
    Eur J Gynaecol Oncol; 2012; 33(6):605-9. PubMed ID: 23327054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.